Purchase Order 75N91021P00759
- Not listed
- Bio-Rad Laboratories, Inc. Life Science Group Division was awarded an $11,619.77 firm fixed price purchase order by the Department of Health and Human Services National Institutes of Health National Cancer Institute on April 1, 2019. The contract has a completion date of January 31, 2024 and no set-aside designation was used. This purchase order is associated with Bio-Rad Laboratories' five-year, $1 billion blanket purchase agreement with the Department of Health and Human Services National...
- This contract was awarded by the National Institutes of Health (NIH) to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of the publicly traded life sciences company Bio-Rad Laboratories, Inc. The $22,853.96 firm-fixed-price purchase order does not have a set-aside designation. It provides for the delivery of various biological research products and associated maintenance services to the NIH. Bio-Rad Laboratories, Inc. holds a $1 billion Blanket Purchase Agreement with the...
- This is a $35,720.00 firm fixed-price purchase order awarded by the Office of Logistics and Acquisition Operations within the Department of Health and Human Services' National Institutes of Health (NIH) to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of the global life sciences company Bio-Rad Laboratories, Inc. The contract is for the provision of imaging equipment, medical/dental/veterinary supplies, and associated warehouse equipment to support NIH's research and...
- The National Cancer Institute awarded a $24,995 firm fixed-price Blanket Purchase Agreement (BPA) call to Bio-Rad Laboratories, Inc.'s Life Science Group Division on September 14, 2016, for laboratory equipment and supplies. The contract was completed by October 7, 2016, with performance at the NCI facility in Bethesda, Maryland. This award was not designated as a small business set-aside, consistent with Bio-Rad's positioning as an established large federal contractor. The call was placed...
- This $16,238.00 firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development, a civilian agency within the Department of Health and Human Services, to Bio-Rad Laboratories, Inc.'s Life Science Group Division. The award does not have a set-aside designation. Bio-Rad Laboratories, Inc. is a leading global manufacturer of products for life science research and clinical diagnostics, including PCR systems, reagents, and other laboratory equipment and...
- Bio-Rad Laboratories, Inc.'s Life Science Group Division was awarded a Blanket Purchase Agreement (BPA) call order valued at $3,292.81 by the National Cancer Institute (NCI), a civilian agency within the National Institutes of Health. This fixed-price redetermination contract, issued on November 25, 2013 with an ultimate completion date of November 28, 2014, was performed in Bethesda, Maryland. The award carried no small business set-aside designation, reflecting Bio-Rad's established position...
- Bio-Rad Laboratories, Inc. Life Science Group Division has been awarded a $16,085.40 firm-fixed-price purchase order by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to provide maintenance services in Bethesda, Maryland. The period of performance is through February 28, 2027. This award is not associated with any set-aside designation. Bio-Rad Laboratories holds a five-year, one billion dollar blanket purchase agreement with the Department...
- Bio-Rad Laboratories, Inc. was awarded a $24,995 firm fixed-price BPA call by the National Cancer Institute on June 26, 2017, for laboratory equipment with an ultimate completion date of July 31, 2017. The contract was performed in Bethesda, Maryland and did not utilize a small business set-aside. Bio-Rad, a global leader in life science research and clinical diagnostics headquartered in Hercules, California, supplied specialized laboratory instrumentation through its Life Science Group...
- Bio-Rad Laboratories, Inc.'s Life Science Group Division has been awarded a $30,298.80 firm fixed-price purchase order by the National Institutes of Health Clinical Center, with an ultimate completion date of January 22, 2027. The contract, which was not subject to small business set-aside designation, was awarded on January 23, 2026, and will be performed at Bio-Rad's facility in Hercules, California. As a global leader in life science research and clinical diagnostics, Bio-Rad will supply...
- This federal contract award to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of Bio-Rad Laboratories, Inc., was issued by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) Office of Acquisitions. The $26,949.12 firm fixed price purchase order does not have a set-aside designation. The contract is for the delivery of laboratory equipment, reagents, and consumables to support biomedical research and testing. Bio-Rad...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $116,503.50 firm-fixed-price purchase order contract to Bio-Rad Laboratories, Inc. Life Science Group Division to acquire three Bio-Rad ChemiDoc MP Imaging Systems and five Criterion vertical cell midi-format electrophoresis apparatuses and associated items for the Center for Cancer Research's Laboratory of Metabolism. This contract was not set aside. Bio-Rad Laboratories, Inc. is a for-profit manufacturer of specialized biotechnology products and services that has provided equipment and supplies to support biomedical research and testing activities at various federal agencies, including the NIH, CDC, and FDA. No subcontractors were identified. Bio-Rad Laboratories, Inc. holds a $1 billion blanket purchase agreement with the NIH Office of Logistics and Acquisition Operations to provide biological materials, chemicals, consumables, and other laboratory resources to sustain the agency's medical research mission.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Acquisition of three (3) Brand Name or Equal Bio-Rad ChemiDoc MP Imaging System and five (5) Criterion vertical cell midi-format electrophoresis apparatus. | 75N91021Q00144 | Department of Health and Human Services National Institutes of Health National Cancer Institute | Solicitation 1/1 | 7/29/21, 11:44 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $116.5k | 9/13/21 |